Write For Us

Sanofi forecasts profit growth amid competition

Sponsored Post Vitamin D2 Canada Persia
56 Views
Published
Sanofi forecast moderate earnings growth this year, with the French drugmaker saying demand for its asthma and eczema drug Dupixent would be partly offset by competition for its multiple sclerosis pill Aubagio.

#News #Reuters #newsfeed #Sanofi #Healthcare #Pharmaceutical

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, news, top news
Sign in or sign up to post comments.
Be the first to comment